ReviewAdvances in experimental medicine and biology2025
Prevention of Sarcopenia.
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This chapter outlines the definition of sarcopenia and the challenges faced by the scientific and clinical community in obtaining a universally accepted definition. Because sarcopenia is a risk factor for a multitude of adverse health outcomes, the chapter discusses the strengths and weaknesses of recent diagnostic criteria (sarcopenia algorithms) to identify older people with sarcopenia outlined by experts across the world. In particular, the assessment tools and their cut-off points (reference values) for muscle mass, strength, and physical performance are highlighted. Attention is also given to the available screening assessment tools, which provide opportunities to identify older people at risk for sarcopenia in large communities or settings. Identifying effective interventions to combat sarcopenia is paramount; thus, the chapter highlights the available published evidence where the participants of the study were identified as sarcopenic based on the established sarcopenia algorithms. The benefits of resistance training, endurance training, power training, high-intensity interval training, multicomponent training, multidomain programs, blood flow restriction, whole-body vibration, Tai Chi, YiJinJing, and Baduanjin in people diagnosed with sarcopenia are reviewed. The most promising nutritional interventions and drug therapies in older people with sarcopenia are also discussed. Lastly, the chapter summarizes the importance of physical activity.
Indexed as
Identifiers
40879947What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.